1921
Volume 94, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract

In February 2014, the Malaria Elimination Working Group, in partnership with the Peruvian Ministry of Health (MoH), hosted its first international conference on malaria elimination in Iquitos, Peru. The 2-day meeting gathered 85 malaria experts, including 18 international panelists, 23 stakeholders from different malaria-endemic regions of Peru, and 11 MoH authorities. The main outcome was consensus that implementing a malaria elimination project in the Amazon region is achievable, but would require: 1) a comprehensive strategic plan, 2) the altering of current programmatic guidelines from control toward elimination by including symptomatic as well as asymptomatic individuals for antimalarial therapy and transmission-blocking interventions, and 3) the prioritization of community-based active case detection with proper rapid diagnostic tests to interrupt transmission. Elimination efforts must involve key stakeholders and experts at every level of government and include integrated research activities to evaluate, implement, and tailor sustainable interventions appropriate to the region.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.15-0369
2016-06-01
2017-09-22
Loading full text...

Full text loading...

/deliver/fulltext/14761645/94/6/1200.html?itemId=/content/journals/10.4269/ajtmh.15-0369&mimeType=html&fmt=ahah

References

  1. WHO, 2014. World Malaria Report. Geneva, Switzerland: WHO.
  2. Gething PW, Elyazar IR, Moyes CL, Smith DL, Battle KE, Guerra CA, Patil AP, Tatem AJ, Howes RE, Myers MF, George DB, Horby P, Wertheim HF, Price RN, Mueller I, Baird JK, Hay SI, , 2012. A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis 6: e1814.[Crossref]
  3. Gething PW, Patil AP, Smith DL, Guerra CA, Elyazar IR, Johnston GL, Tatem AJ, Hay SI, , 2011. A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar J 10: 378.[Crossref]
  4. The malERA Consultative Group on Vaccines, 2011. A research agenda for malaria eradication: vaccines. PLoS Med 8: e1000398.[Crossref]
  5. Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, Temperley WH, Kabaria CW, Tatem AJ, Manh BH, Elyazar IR, Baird JK, Snow RW, Hay SI, , 2010. The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis 4: e774.[Crossref]
  6. Baird JK, , 2010. Eliminating malaria—all of them. Lancet 376: 18831885.[Crossref]
  7. Bousema T, Drakeley C, , 2011. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev 24: 377410.[Crossref]
  8. Douglas NM, Pontororing GJ, Lampah DA, Yeo TW, Kenangalem E, Poespoprodjo J, Ralph AP, Bangs MJ, Sugiarto P, Anstey NM, Price RN, , 2014. Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia. BMC Med 12: 217.[Crossref]
  9. Lee G, Yori P, Olortegui MP, Pan W, Caulfield L, Gilman RH, Sanders JW, Delgado HS, Kosek M, , 2012. Comparative effects of vivax malaria, fever and diarrhoea on child growth. Int J Epidemiol 41: 531539.[Crossref]
  10. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM, , 2007. Vivax malaria: neglected and not benign. Am J Trop Med Hyg 77: 7987.
  11. Price RN, Douglas NM, Anstey NM, , 2009. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr Opin Infect Dis 22: 430435.[Crossref]
  12. Arevalo-Herrera M, Quinones ML, Guerra C, Cespedes N, Giron S, Ahumada M, Pineros JG, Padilla N, Terrientes Z, Rosas A, Padilla JC, Escalante AA, Beier JC, Herrera S, , 2012. Malsaria in selected non-Amazonian countries of Latin America. Acta Trop 121: 303314.[Crossref]
  13. Parker BS, Paredes Olortegui M, Penataro Yori P, Escobedo K, Florin D, Rengifo Pinedo S, Cardenas Greffa R, Capcha Vega L, Rodriguez Ferrucci H, Pan WK, Banda Chavez C, Vinetz JM, Kosek M, , 2013. Hyperendemic malaria transmission in areas of occupation-related travel in the Peruvian Amazon. Malar J 12: 178.[Crossref]
  14. Kosek M, Yori PP, Gilman RH, Calderon M, Zimic M, Chuquiyauri R, Jeri C, Pinedo-Cancino V, Matthias MA, Llanos-Cuentas A, Vinetz JM, , 2012. High degree of Plasmodium vivax diversity in the Peruvian Amazon demonstrated by tandem repeat polymorphism analysis. Am J Trop Med Hyg 86: 580586.[Crossref]
  15. Branch O, Casapia WM, Gamboa DV, Hernandez JN, Alava FF, Roncal N, Alvarez E, Perez EJ, Gotuzzo E, , 2005. Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community. Malar J 4: 27.[Crossref]
  16. Bautista CT, Chan AS, Ryan JR, Calampa C, Roper MH, Hightower AW, Magill AJ, , 2006. Epidemiology and spatial analysis of malaria in the northern Peruvian Amazon. Am J Trop Med Hyg 75: 12161222.
  17. Vinetz JM, Gilman RH, , 2002. Asymptomatic Plasmodium parasitemia and the ecology of malaria transmission. Am J Trop Med Hyg 66: 639640.
  18. Roshanravan B, Kari E, Gilman RH, Cabrera L, Lee E, Metcalfe J, Calderon M, Lescano AG, Montenegro SH, Calampa C, Vinetz JM, , 2003. Endemic malaria in the Peruvian Amazon region of Iquitos. Am J Trop Med Hyg 69: 4552.
  19. da Silva-Nunes M, Moreno M, Conn JE, Gamboa D, Abeles S, Vinetz JM, Ferreira MU, , 2012. Amazonian malaria: asymptomatic human reservoirs, diagnostic challenges, environmentally driven changes in mosquito vector populations, and the mandate for sustainable control strategies. Acta Trop 121: 281291.[Crossref]
  20. Chuquiyauri R, Paredes M, Penataro P, Torres S, Marin S, Tenorio A, Brouwer KC, Abeles S, Llanos-Cuentas A, Gilman RH, Kosek M, Vinetz JM, , 2012. Socio-demographics and the development of malaria elimination strategies in the low transmission setting. Acta Trop 121: 292302.[Crossref]
  21. Chuquiyauri R, Penataro P, Brouwer KC, Fasabi M, Calderon M, Torres S, Gilman RH, Kosek M, Vinetz JM, , 2013. Microgeographical differences of Plasmodium vivax relapse and re-infection in the Peruvian Amazon. Am J Trop Med Hyg 89: 326338.[Crossref]
  22. Quispe AM, Pozo E, Guerrero E, Durand S, Baldeviano GC, Edgel KA, Graf PC, Lescano AG, , 2014. Plasmodium vivax hospitalizations in a monoendemic malaria region: severe vivax malaria? Am J Trop Med Hyg 91: 1117.[Crossref]
  23. Gamboa D, Ho MF, Bendezu J, Torres K, Chiodini PL, Barnwell JW, Incardona S, Perkins M, Bell D, McCarthy J, Cheng Q, , 2010. A large proportion of P. falciparum isolates in the Amazon region of Peru lack PfHRP2 and PfHRP3: implications for malaria rapid diagnostic tests. PLoS One 5: e8091.
  24. Akinyi S, Hayden T, Gamboa D, Torres K, Bendezu J, Abdallah JF, Griffing SM, Quezada WM, Arrospide N, De Oliveira AM, Lucas C, Magill AJ, Bacon DJ, Barnwell JW, Udhayakumar V, , 2013. Multiple genetic origins of histidine-rich protein 2 gene deletion in Plasmodium falciparum parasites from Peru. Sci Rep 3: 2797.[Crossref]
  25. Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, Arthur P, Chuenchom N, Mohrle JJ, Duparc S, Ugwuegbulam C, Kleim JP, Carter N, Green JA, Kellam L, , 2014. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study. Lancet 383: 10491058.[Crossref]
  26. de Oliveira AM, Chavez J, de Leon GP, Durand S, Arrospide N, Roberts J, Cabezas C, Marquino W, , 2011. Efficacy and effectiveness of mefloquine and artesunate combination therapy for uncomplicated Plasmodium falciparum malaria in the Peruvian Amazon. Am J Trop Med Hyg 85: 573578.[Crossref]
  27. Gutman J, Green M, Durand S, Rojas OV, Ganguly B, Quezada WM, Utz GC, Slutsker L, Ruebush TK, 2nd Bacon DJ, , 2009. Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria. Malar J 8: 58.[Crossref]
  28. Marquiino W, Huilca MH, Calampa C, Falconi E, Cabezas C, Naupay R, Ruebush TK, 2nd, 2003. Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon basin of Peru. Am J Trop Med Hyg 68: 608612.
  29. Durand S, Cabezas C, Lescano AG, Galvez M, Gutierrez S, Arrospide N, Alvarez C, Santolalla ML, Bacon DJ, Graf PC, , 2014. Efficacy of three different regimens of primaquine for the prevention of relapses of Plasmodium vivax malaria in the Amazon basin of Peru. Am J Trop Med Hyg 91: 1826.[Crossref]
  30. Grietens KP, Soto V, Erhart A, Ribera JM, Toomer E, Tenorio A, Montalvo TG, Rodriguez H, Cuentas AL, D'Alessandro U, Gamboa D, , 2010. Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon. Am J Trop Med Hyg 82: 10171023.[Crossref]
  31. Grande T, Bernasconi A, Erhart A, Gamboa D, Casapia M, Delgado C, Torres K, Fanello C, Llanos-Cuentas A, D'Alessandro U, , 2007. A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru. PLoS One 2: e1101.[Crossref]
  32. Ruebush TK, 2nd Zegarra J, Cairo J, Andersen EM, Green M, Pillai DR, Marquino W, Huilca M, Arevalo E, Garcia C, Solary L, Kain KC, , 2003. Chloroquine-resistant Plasmodium vivax malaria in Peru. Am J Trop Med Hyg 69: 548552.
  33. Bacon DJ, McCollum AM, Griffing SM, Salas C, Soberon V, Santolalla M, Haley R, Tsukayama P, Lucas C, Escalante AA, Udhayakumar V, , 2009. Dynamics of malaria drug resistance patterns in the Amazon basin region following changes in Peruvian national treatment policy for uncomplicated malaria. Antimicrob Agents Chemother 53: 20422051.[Crossref]
  34. Magill AJ, Zegarra J, Garcia C, Marquino W, Ruebush TK, 2nd, 2004. Efficacy of sulfadoxine-pyrimethamine and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon basin of Peru. Rev Soc Bras Med Trop 37: 279281.[Crossref]
  35. Marquino W, MacArthur JR, Barat LM, Oblitas FE, Arrunategui M, Garavito G, Chafloque ML, Pardave B, Gutierrez S, Arrospide N, Carrillo C, Cabezas C, Ruebush TK, 2nd, 2003. Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru. Am J Trop Med Hyg 68: 120123.
  36. Marquino W, Ylquimiche L, Hermenegildo Y, Palacios AM, Falconi E, Cabezas C, Arrospide N, Gutierrez S, Ruebush TK, 2nd, 2005. Efficacy and tolerability of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine alone for the treatment of uncomplicated Plasmodium falciparum malaria in Peru. Am J Trop Med Hyg 72: 568572.
  37. Sachs P, Diaz Rodriguez GA, Briceno I, King R, Achee NL, Grieco JP, , 2013. Comparison of experimental hut entrance and exit behavior between Anopheles darlingi from the Cayo District, Belize, and Zungarococha, Peru. J Am Mosq Control Assoc 29: 319327.[Crossref]
  38. Sachs P, Achee N, Riner D, Grieco J, , 2010. Field evaluation of the behavioral differences associated with two geographically isolated populations of Anopheles darlingi . Am J Trop Med Hyg 83: 182.
  39. Vittor AY, Gilman RH, Tielsch J, Glass G, Shields T, Lozano WS, Pinedo-Cancino V, Patz JA, , 2006. The effect of deforestation on the human-biting rate of Anopheles darlingi, the primary vector of falciparum malaria in the Peruvian Amazon. Am J Trop Med Hyg 74: 311.
  40. Reinbold-Wasson DD, Sardelis MR, Jones JW, Watts DM, Fernandez R, Carbajal F, Pecor JE, Calampa C, Klein TA, Turell MJ, , 2012. Determinants of Anopheles seasonal distribution patterns across a forest to periurban gradient near Iquitos, Peru. Am J Trop Med Hyg 86: 459463.[Crossref]
  41. Mirabello L, Vineis JH, Yanoviak SP, Scarpassa VM, Povoa MM, Padilla N, Achee NL, Conn JE, , 2008. Microsatellite data suggest significant population structure and differentiation within the malaria vector Anopheles darlingi in Central and South America. BMC Ecol 8: 3.[Crossref]
  42. Pinedo-Cancino V, Sheen P, Tarazona-Santos E, Oswald WE, Jeri C, Vittor AY, Patz JA, Gilman RH, , 2006. Limited diversity of Anopheles darlingi in the Peruvian Amazon region of Iquitos. Am J Trop Med Hyg 75: 238245.
  43. Conn JE, Moreno M, Saavedra M, Bickersmith SA, Knoll E, Fernandez R, Vera H, Burrus RG, Lescano AG, Sanchez JF, Rivera E, Vinetz JM, , 2013. Molecular taxonomy of Anopheles (Nyssorhynchus) benarrochi (Diptera: Culicidae) and malaria epidemiology in southern Amazonian Peru. Am J Trop Med Hyg 88: 319324.[Crossref]
  44. Moreno M, Tong C, Guzman M, Chuquiyauri R, Llanos-Cuentas A, Rodriguez H, Gamboa D, Meister S, Winzeler EA, Maguina P, Conn JE, Vinetz JM, , 2014. Infection of laboratory-colonized Anopheles darlingi mosquitoes by Plasmodium vivax . Am J Trop Med Hyg 90: 612616.[Crossref]
  45. Bharti AR, Chuquiyauri R, Brouwer KC, Stancil J, Lin J, Llanos-Cuentas A, Vinetz JM, , 2006. Experimental infection of the neotropical malaria vector Anopheles darlingi by human patient-derived Plasmodium vivax in the Peruvian Amazon. Am J Trop Med Hyg 75: 610616.
  46. Abeles SR, Chuquiyauri R, Tong C, Vinetz JM, , 2013. Human host-derived cytokines associated with Plasmodium vivax transmission from acute malaria patients to Anopheles darlingi mosquitoes in the Peruvian Amazon. Am J Trop Med Hyg 88: 11301137.[Crossref]
  47. Aramburú Guarda J, Ramal Asayag C, Witzig R, , 1999. Malaria reemergence in the Peruvian Amazon region. Emerg Infect Dis 5: 209215.[Crossref]
  48. Griffing SM, Gamboa D, Udhayakumar V, , 2013. The history of 20th century malaria control in Peru. Malar J 12: 303.[Crossref]
  49. Roberts DR, Laughlin LL, Hsheih P, Legters LJ, , 1997. DDT, global strategies, and a malaria control crisis in South America. Emerg Infect Dis 3: 295302.[Crossref]
  50. Williams HA, Vincent-Mark A, Herrera Y, Chang OJ, , 2009. A retrospective analysis of the change in anti-malarial treatment policy: Peru. Malar J 8: 85.[Crossref]
  51. Neyra D, Cabezas CK, Ruebush TK, 2nd, 2003. El proceso de adecuación y cambio en la política del tratamiento de la malaria por Plasmodium falciparum en el Perú, 1990–2001. Rev Peru Med Exp Salud Publica 20: 162171.
  52. PAMAFRO, 2009. Compartiendo Lecciones Aprendidas Del PAMAFRO. Available at: http://www.orasconhu.org/pamafro/compartiendo-lecciones-aprendidas-del-pamafro. Accessed May 1, 2015.
  53. Grietens KP, Muela Ribera J, Soto V, Tenorio A, Hoibak S, Aguirre AR, Toomer E, Rodriguez H, Llanos Cuentas A, D'Alessandro U, Gamboa D, Erhart A, , 2013. Traditional nets interfere with the uptake of long-lasting insecticidal nets in the Peruvian Amazon: the relevance of net preference for achieving high coverage and use. PLoS One 8: e50294.[Crossref]
  54. Harvey SA, Olortegui MP, Leontsini E, Pezo CB, Pezantes LM, Winch PJ, , 2008. The whole world will be able to see us: determining the characteristics of a culturally appropriate bed net among mestizo communities of the Peruvian Amazon. Am J Trop Med Hyg 79: 834838.
  55. MINSA-DGE, 2015. Situational Room Report: Epidemiological Week 01. Peru: Ministerio de Salud del Perú, Dirección General de Epidemiología.
  56. Delgado-Ratto C, Soto-Calle VE, Van den Eede P, Gamboa D, Rosas A, Abatih EN, Rodriguez Ferrucci H, Llanos-Cuentas A, Van Geertruyden JP, Erhart A, D'Alessandro U, , 2014. Population structure and spatio-temporal transmission dynamics of Plasmodium vivax after radical cure treatment in a rural village of the Peruvian Amazon. Malar J 13: 8.[Crossref]
  57. Baldeviano GC, Akinyi S, Arrospide S, Gonzalez RV, Sanchez JF, Macedo S, Conde S, Tapia L, Salas C, Gamboa D, Herrera Y, Edgel AG, Udhayakumar V, Lescano AG, , 2015. Molecular epidemiology of Plasmodium falciparum malaria outbreak, Tumbes, Peru, 2010–2012. Emerg Infect Dis 21: 797803.[Crossref]
  58. Guthmann JP, Hall AJ, Jaffar S, Palacios A, Lines J, Llanos-Cuentas A, , 2001. Environmental risk factors for clinical malaria: a case-control study in the Grau region of Peru. Trans R Soc Trop Med Hyg 95: 577583.[Crossref]
  59. Rosas-Aguirre A, Llanos-Cuentas A, Speybroeck N, Cook J, Contreras-Mancilla J, Soto V, Gamboa D, Pozo E, Ponce OJ, Pereira MO, Soares IS, Theisen M, D'Alessandro U, Erhart A, , 2013. Assessing malaria transmission in a low endemicity area of north-western Peru. Malar J 12: 339.[Crossref]
  60. Maltha J, Gamboa D, Bendezu J, Sanchez L, Cnops L, Gillet P, Jacobs J, , 2012. Rapid diagnostic tests for malaria diagnosis in the Peruvian Amazon: impact of PfHRP2 gene deletions and cross-reactions. PLoS One 7: e43094.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.15-0369
Loading
/content/journals/10.4269/ajtmh.15-0369
Loading

Data & Media loading...

  • Received : 18 May 2015
  • Accepted : 07 Feb 2016

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error